Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹122 Cr
Revenue (TTM)
₹33 Cr
Net Profit (TTM)
₹2 Cr
ROE
-12.3 %
ROCE
-12.3 %
P/E Ratio
64.8
P/B Ratio
1.2
Industry P/E
--
EV/EBITDA
50.5
Div. Yield
0 %
Debt to Equity
0
Book Value
₹9.1
EPS
₹1.1
Face value
10
Shares outstanding
112,358,203
CFO
₹-0.01 Cr
EBITDA
₹-0.25 Cr
Net Profit
₹0.10 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Welcure Drugs
| -6.3 | 30.5 | 44.7 | 102.6 | 22.2 | 83.6 | 25.3 |
|
BSE Healthcare
| -5.7 | 2.2 | 5.8 | 19.5 | 22.9 | 22.6 | 9.7 |
|
BSE Small Cap
| -6.6 | 6.8 | 11.2 | 6.8 | 24.8 | 37.4 | 16.4 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Welcure Drugs
| 195.4 | -31.0 | -26.2 | 234.6 | 353.1 | -5.8 | -55.2 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Welcure Drugs
|
10.9 | 122.5 | 33.4 | 1.9 | 7.0 | 3.7 | 64.8 | 1.2 |
| 1,193.2 | 9,744.0 | 1,006.9 | 160.4 | 20.4 | 12.6 | 61.4 | 7.4 | |
| 1,404.6 | 6,117.2 | 4,790.9 | 97.2 | 2.6 | 5.4 | 67.9 | 3.6 | |
| 517.9 | 12,549.2 | 4,460.0 | 479.1 | 16.4 | 14.4 | 26.2 | 3.5 | |
| 23.9 | 10.5 | 29.1 | -0.3 | 7.6 | -258.7 | -- | 2.1 | |
| 43.1 | 56.2 | 26.4 | -3.4 | -14.1 | -2.8 | -- | 0.5 | |
| 39.1 | 24.6 | 0.2 | 0.2 | -120.5 | 2.5 | 104.8 | 2.6 | |
| 5,373.5 | 8,894.0 | 1,159.5 | 236.6 | 28.3 | 43.8 | 37.6 | 14.6 | |
| 21.0 | 11.5 | 0.7 | -0.3 | -39.3 | -55.6 | -- | 23.2 | |
| 2.8 | 11.2 | 7.4 | -0.7 | -5.1 | -15.2 | -- | 2.8 |
No Review & Analysis are available.
Welcure Drugs & Pharmaceuticals Limited engages in the wholesale of pharmaceutical and medical goods in India. The company was incorporated in 1996 and is based in Delhi, India.
Incorporated
1996
Chairman
--
Managing Director
--
Headquarters
Delhi, Delhi
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Welcure Drugs & Pharmaceuticals Ltd stood at ₹ 270 Cr as on 31-Dec-24
The share price of Welcure Drugs & Pharmaceuticals Ltd is ₹10.94 (BSE) as of 21-May-2025 16:01 IST. Welcure Drugs & Pharmaceuticals Ltd has given a return of 22.17% in the last 3 years.
Welcure Drugs & Pharmaceuticals Ltd has a market capitalisation of ₹ 122 Cr as on 21-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Welcure Drugs & Pharmaceuticals Ltd is 1.20 times as on 21-May-2025, a 56% discount to its peers’ median range of 2.71 times.
The P/E ratio of Welcure Drugs & Pharmaceuticals Ltd is 64.80 times as on 21-May-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Welcure Drugs & Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Welcure Drugs & Pharmaceuticals Ltd.
Welcure Drugs & Pharmaceuticals Limited engages in the wholesale of pharmaceutical and medical goods in India. The company was incorporated in 1996 and is based in Delhi, India.
There is no promoters in Welcure Drugs & Pharmaceuticals Ltd.
There is no promoter pledging in Welcure Drugs & Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
6,433
|
|
|
53
|
|
|
28
|
|
|
12
|
|
|
10
|
|
|
8
|
|
|
12,274
|
|
|
9,199
|
|
|
8,615
|
| Welcure Drugs & Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
3.66
|
|
Operating margin(%)
|
6.99
|
|
Net Margin(%)
|
5.65
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Welcure Drugs & Pharmaceuticals Ltd was ₹2 Cr.
₹-0.33
(
